Vanessa Zaiatz-Bittencourt

Vanessa Zaiatz-Bittencourt

Auto-generated profile, based on publicly available information

Vanessa Zaiatz-Bittencourt

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; and

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2017 in Nature Immunology
Verified
Journal Article
Closed access
NANadine Assmann
Nadine Assmann
KOKatie L O'Brien
Katie L O'Brien
RDRaymond P Donnelly
Raymond P Donnelly
LDLydia Dyck
Lydia Dyck
VZVanessa Zaiatz-Bittencourt
Vanessa Zaiatz-Bittencourt
David K. FinlayDavid K. Finlay
David K. Finlay

15 March 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SKSinéad E Keating
Sinéad E Keating
VZVanessa Zaiatz-Bittencourt
Vanessa Zaiatz-Bittencourt
RLRoisín M. Loftus
Roisín M. Loftus
CKCiara Keane
Ciara Keane
KBKiva Brennan
Kiva Brennan
CGClair M. Gardiner
Clair M. Gardiner
Human NK cells can be classified into phenotypically and functionally distinct subsets based on levels of CD56 receptor. CD56dim cells are generally considered more cytotoxic, whereas the CD56bright cells are potent producers of IFN-γ. In this study, we define the metabolic changes that occur in peripheral blood NK cells in response to cytokine. Metabolic analysis showed that NK cells upregulate glycolysis and oxidative phosphorylation in response to either IL-2 or IL-12/15 cytokine combinations. Despite the fact that both these cytokine combinations robustly upregulated mammalian Target of Rapamycin Complex 1 in human NK cells, only the IL-2–induced metabolic changes were sensitive to mammalian Target of Rapamycin Complex 1 inhibition by rapamycin. Interestingly, we found that CD56bright cells were more metabolically active compared with CD56dim cells. They preferentially upregulated nutrient receptors and also differed substantially in terms of their glucose metabolism. CD56bright cells expressed high levels of the glucose uptake receptor, Glut1 (in the absence of any cytokine), and had higher rates of glucose uptake compared with CD56dim cells. Elevated levels of oxidative phosphorylation were required to support both cytotoxicity and IFN-γ production in all NK cells. Finally, although elevated glycolysis was not required directly for NK cell degranulation, limiting the rate of glycolysis significantly impaired IFN-γ production by the CD56bright subset of cells. Overall, we have defined CD56bright NK cells to be more metabolically active than CD56dim cells, which supports their production of large amounts of IFN-γ during an immune response.

1 January 2012 in Biochemistry Research International
Verified
Journal Article
Open access
PDF file
MSMairim Alexandra Solis
Mairim Alexandra Solis
YCYing-Hui Chen
Ying-Hui Chen
TWTzyy Yue Wong
Tzyy Yue Wong
VBVanessa Zaiatz Bittencourt
Vanessa Zaiatz Bittencourt
YLYen-Cheng Lin
Yen-Cheng Lin
LHLing-Huei Huang
Ling-Huei Huang
Hyaluronan is a linear glycosaminoglycan that has received special attention in the last few decades due to its extraordinary physiological functions. This highly viscous polysaccharide is not only a lubricator, but also a significant regulator of cellular behaviors during embryogenesis, morphogenesis, migration, proliferation, and drug resistance in many cell types, including stem cells. Most hyaluronan functions require binding to its cellular receptors CD44, LYVE-1, HARE, layilin, and RHAMM. After binding, proteins are recruited and messages are sent to alter cellular activities. When low concentrations of hyaluronan are applied to stem cells, the proliferative activity is enhanced. However, at high concentrations, stem cells acquire a dormant state and induce a multidrug resistance phenotype. Due to the influence of hyaluronan on cells and tissue morphogenesis, with regards to cardiogenesis, chondrogenesis, osteogenesis, and neurogenesis, it is now been utilized as a biomaterial for tissue regeneration. This paper summarizes the most important and recent findings regarding the regulation of hyaluronan in cells.

15 June 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
VZVanessa Zaiatz-Bittencourt
Vanessa Zaiatz-Bittencourt
David K. FinlayDavid K. Finlay
David K. Finlay
CGClair M. Gardiner
Clair M. Gardiner
Cytokines stimulate rapid metabolic changes in human NK cells, including increases in both glycolysis and oxidative phosphorylation pathways. However, how these are subsequently regulated is not known. In this study, we demonstrate that TGF-β can inhibit many of these metabolic changes, including oxidative phosphorylation, glycolytic capacity, and respiratory capacity. TGF-β also inhibited cytokine-induced expression of the transferrin nutrient receptor CD71. In contrast to a recent report on murine NK cells, TGF-β–mediated suppression of these metabolic responses did not involve the inhibition of the metabolic regulator mTORC1. Inhibition of the canonical TGF-β signaling pathway was able to restore almost all metabolic and functional responses that were inhibited by TGF-β. These data suggest that pharmacological inhibition of TGF-β could provide a metabolic advantage to NK cells that is likely to result in improved functional responses. This has important implications for NK cell–based cancer immunotherapies.

10 March 2021 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
VBVanessa Zaiatz Bittencourt
Vanessa Zaiatz Bittencourt
FJFiona Jones
Fiona Jones
GDGlen Doherty
Glen Doherty
ERElizabeth J Ryan
Elizabeth J Ryan
The cells of the immune system are highly dynamic, constantly sensing and adapting to changes in their surroundings. Complex metabolic pathways govern leukocytes’ ability to fine-tune their responses to external threats. Mammalian target of rapamycin complex 1 and hypoxia inducible factor are important hubs of these pathways and play a critical role coordinating cell activation and proliferation and cytokine production. For this reason, these molecules are attractive therapeutic targets in inflammatory disease. Insight into perturbations in immune cell metabolic pathways and their impact on inflammatory bowel disease (IBD) progression are starting to emerge. However, it remains to be determined whether the aberrations in immune metabolism that occur in gut resident immune cells contribute to disease pathogenesis or are reflected in the peripheral blood of patients with IBD. In this review, we explore what is known about the metabolic profile of T cells, monocytes, macrophages, dendritic cells, and natural killer cells in IBD and discuss the potential of manipulating immune cell metabolism as a novel approach to treating IBD.

15 February 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VZVanessa Zaiatz-Bittencourt
Vanessa Zaiatz-Bittencourt
FJFiona Jones
Fiona Jones
MTMiriam Tosetto
Miriam Tosetto
CSCaitriona Scaife
Caitriona Scaife
GCGerard Cagney
Gerard Cagney
ERElizabeth J. Ryan
Elizabeth J. Ryan
The gut microbiota regulates chronic inflammation and has been implicated in the pathogenesis of a broad spectrum of disease including autoimmunity and cancer. Microbial short-chain fatty acids (SCFAs) e.g., butyrate have demonstrated immunomodulatory effects and are thought to be key mediators of the host-microbiome interaction. Here, we investigated the effect of butyrate on effector functions of blood derived human NK cells stimulated for 18 h with a combination of IL-12/IL-15, a potent mix of cytokines that drive NK cell activation. We show that butyrate has a strong anti-inflammatory effect on NK cells. NK cells cultured in the presence of butyrate expressed lower levels of activating receptors (TRAIL, NKp30, NKp44) and produced lower levels of cytokines (IFNγ, TNF-α, IL-22, granzyme B, granzyme A, perforin) in response to IL-12/IL-15. Butyrate restricted NK cell function by downregulation of mTORC1 activity, c-Myc mRNA expression and metabolism. Using a shotgun proteomic approach, we confirmed the effect of butyrate on NK cell cytokine signaling and metabolism and identified BRD2, MAT2A and EHD1 as downstream mediators of these effects. This insight into the immunomodulatory activity of butyrate on human NK cell function might help to develop new ways to limit NK cell function during chronic inflammation.